Siponimod vs placebo
Mean number of gadolinium‐enhancing lesions on T1‐weighted brain MRI image at 6 months · people with multiple sclerosis
It is very uncertain whether siponimod changes mean number of gadolinium‐enhancing lesions on T1‐weighted brain MRI… compared with placebo (very low certainty).
1 finding from 1 review
- RR 0.14 [0.1, 0.19]1 study · 1641 participantsVery low